2025 · 3rd Quarter (July 1 - Sep 30)
Filed by ORGANOGENESIS INC..
Open official filingSource-reported fields
Expense method: C
Literal source text
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill
Literal federal measure citations: S. 2561
FDA policy on chronic wound healing products
Discussion around new company manufacturing facilities located in Smithfield, Rhode Island.
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.
